Many companies experience cycles in which revenue growth and cost cutting alternate in focus. While these cycles are understandable, they often damage long-term profitability. In this article, Monitor's Robert Browne, Josh Lee, Mike Standing and Lisa S. Thompson present the Delivering Measurable Results approach, which helps firms escape these cycles of revenue growth and cost cutting by developing programs that can sustainably improve their margins.

Determining and communicating the economic value of a product is one of the major strategic imperatives for the pharmaceutical industry as regulatory agencies move toward comparative effectiveness approaches and value-based pricing. Monitor’s Comparative Clinical and Economic Value (CCEV™) approach enables companies to apply economic-value-based thinking across the entire development, commercialization and health care delivery process.

For executives at manufacturing firms, there is constant pressure to lower costs. While doing so may help the firm survive, executives can make the firm truly succeed by also looking at the other side of the profit equation—driving revenues through value-based pricing, explain Monitor’s Lisa S. Thompson and Joseph Zale.

The slowed growth experienced by the German medical devices market, a large, global industry with a history of innovation and profit, requires targeted and pragmatic responses from industry leaders. In this article, the authors explain how companies can use value-based pricing systems to optimize their bottom line and avoid being caught in the downward spiral that comes with reactionary price cutting.

In this article, Monitor’s Thomas Nagle and Lisa T. Thompson explain how companies can create profitable business models by integrating marketing and operations decision-making. In choosing revenue sources that leverage their strengths, and defining elements of sales that cause functional costs to vary, companies find growth.

The world’s rapidly growing megacities represent significant opportunities for companies seeking new markets and justify a unique approach to an important source of potential growth. In this article, Jennifer Lacks Kaplan and Mark Pocharski explain what it takes for companies to build winning strategies to take advantage of this growth opportunity.